Anthropic accuses Alibaba of campaign to 'brazenly' and 'illicitly' extract AI capabilities CNBC · markets 14m ago Read
Anthropic accuses Alibaba of campaign to 'brazenly' and 'illicitly' extract AI capabilities CNBC · economy 14m ago Read
New website names and shames companies that still don’t offer passkeys to users TechCrunch · tech 28m ago Read
White House requests $87.6 billion supplemental spending for Iran war, farm aid CNBC · economy 33m ago Read
JPMorgan Chase unveils $50 billion buyback, Goldman Sachs raises dividend after Fed stress test CNBC · economy 34m ago Read
Vanguard S&P 500 Growth ETF vs iShares Russell 2000 Growth ETF: Which Growth Stock Fund Is the Better Buy? NASDAQ · markets 43m ago Read
Shortage of Chemotherapy Drugs Brings Rationing Fears for Cancer Patients The New York Times · health 50m ago Read
After Splashy Venice Debut, Florentina Holzinger’s ‘Seaworld’ is Coming to Berlin, Brooklyn ARTnews · culture 54m ago Read
This AI Infrastructure Stock Is Up 14X in the Last Year (Hint: It's Not Micron) NASDAQ · markets 1h ago Read
Actress Julia Ormond Threatens Top 200 Collector Michael Ovitz With Bench Warrant ARTnews · culture 1h ago Read
Micron stock jumps 12% as soaring prices from memory crunch lead to quadrupling of revenue CNBC · markets 1h ago Read
Companies are scrambling to stop employees from maxing out AI budgets with small tasks TechCrunch · tech 1h ago Read
Micron stock jumps 12% as soaring prices from memory crunch lead to quadrupling of revenue CNBC · economy 1h ago Read
Federal Reserve says U.S. banks can withstand $708 billion in losses amid overhaul of capital rules CNBC · economy 1h ago Read
CBL Stock Doubled in a Year. So What Should Investors Make Of This Insider Sale? NASDAQ · markets 1h ago Read
HSBC's Oden Highlights Potential in Chip Sector Amid Market Volatility & AI Growth Bloomberg · technology 1h ago Read
Prediction: SpaceX Will Reach This Price in July (Hint: It's Going to Plummet) NASDAQ · markets 1h ago Read
Medical Hedge Fund Sells 281,000 Shares of Enliven Theapeutics. Is it Time to Sell ELVN? NASDAQ · markets 1h ago Read
